Viewing Study NCT04451720


Ignite Creation Date: 2025-12-25 @ 4:10 AM
Ignite Modification Date: 2026-03-14 @ 2:55 AM
Study NCT ID: NCT04451720
Status: COMPLETED
Last Update Posted: 2022-12-05
First Post: 2020-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Palmoplantar Pustulosis (PPP) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Palmoplantar Pustulosis (PPP) View
None Risankizumab View
None SKYRIZI View